2.16.840.1.113883.5.1070/static-2012-07-24 - Versionsgeschichte

ADbot: Automated TermBot page content

2012-11-18T13:18:20Z

Automated TermBot page content

ADbot: Automated TermBot page content

2012-11-18T12:43:23Z

Automated TermBot page content

ADbot: Automated TermBot page content

2012-11-11T18:48:04Z

Automated TermBot page content

ADbot: Automated TermBot page content

2012-11-11T13:12:05Z

Automated TermBot page content

ADbot: Automated TermBot page content

2012-10-20T12:11:16Z

Automated TermBot page content

ADbot: Automated TermBot page content

2012-10-20T12:07:27Z

Automated TermBot page content

Neue Seite

{| cellspacing="3" cellpadding="2" style="border: 1px solid grey;"
|-
! colspan=2 align="left" bgcolor="#ECE9E4"|'''Codesystem Name'''
|bgcolor="#ECE9E4"|'''Codesystem Id'''
|bgcolor="#ECE9E4"|'''Version / Eingangsdatum'''
|bgcolor="#ECE9E4"|'''Status'''
|-
| colspan=2 bgcolor="#F6F3EE"|''substanceAdminSubstitution''
| bgcolor="#F6F3EE"|2.16.840.1.113883.5.1070
| bgcolor="#F6F3EE"|2012-07-24
| bgcolor="#F6F3EE"|definitiv
|-
! bgcolor="#ECE9E4" align="left"|'''Level/Typ'''
| bgcolor="#ECE9E4"|'''Code'''
| bgcolor="#ECE9E4"|'''Anzeigename'''
| bgcolor="#ECE9E4" colspan="2"|'''Beschreibung'''
|-
|-
|0-A
|_ActSubstanceAdminSubstitutionCode
|(en-US) ActSubstanceAdminSubstitutionCode
| colspan="2" |Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.
|-
|1-S
|'''E'''
|(en-US) equivalent
| colspan="2" |Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.
|-
|2-S
|'''EC'''
|(en-US) equivalent composition
| colspan="2" |Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril
|-
|3-L
|'''BC'''
|(en-US) brand composition
| colspan="2" |Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven
|-
|3-L
|'''G'''
|(en-US) generic composition
| colspan="2" |Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
|-
|2-S
|'''TE'''
|(en-US) therapeutic alternative
| colspan="2" |Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet
|-
|3-L
|'''TB'''
|(en-US) therapeutic brand
| colspan="2" |Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics> Examples: Zantac for Tagamet
|-
|3-L
|'''TG'''
|(en-US) therapeutic generic
| colspan="2" |Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands> Examples: Ranitidine for cimetidine
|-
|1-L
|'''F'''
|(en-US) formulary
| colspan="2" |Description: This substitution was performed or is permitted based on formulary guidelines.
|-
|1-L
|'''N'''
|(en-US) none
| colspan="2" |No substitution occurred or is permitted.

← Nächstältere Version		Version vom 20. Oktober 2012, 12:11 Uhr
Zeile 67:		Zeile 67:
	\|<font color="grey">(en-US)</font> none		\|<font color="grey">(en-US)</font> none
	\| colspan="2" \|<p>No substitution occurred or is permitted.</p>		\| colspan="2" \|<p>No substitution occurred or is permitted.</p>
		+	\|}

@@ Zeile 20: / Zeile 20: @@
 |0-A
 |_ActSubstanceAdminSubstitutionCode
-|[[Datei:EN-US.png]]ActSubstanceAdminSubstitutionCode
+|[[Datei:EN-US.png]] ActSubstanceAdminSubstitutionCode
 | colspan="2" |<p>Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.</p>
 |-
 |1-S
 |'''E'''
-|[[Datei:EN-US.png]]equivalent
+|[[Datei:EN-US.png]] equivalent
 | colspan="2" |<p>Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.</p>
 |-
 |2-S
 |'''EC'''
-|[[Datei:EN-US.png]]equivalent composition
+|[[Datei:EN-US.png]] equivalent composition
 | colspan="2" |<p>Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril</p>
 |-
 |3-L
 |'''BC'''
-|[[Datei:EN-US.png]]brand composition
+|[[Datei:EN-US.png]] brand composition
 | colspan="2" |<p>Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven</p>
 |-
 |3-L
 |'''G'''
-|[[Datei:EN-US.png]]generic composition
+|[[Datei:EN-US.png]] generic composition
 | colspan="2" |<p>Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)</p>
 |-
 |2-S
 |'''TE'''
-|[[Datei:EN-US.png]]therapeutic alternative
+|[[Datei:EN-US.png]] therapeutic alternative
 | colspan="2" |<p>Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet</p>
 |-
 |3-L
 |'''TB'''
-|[[Datei:EN-US.png]]therapeutic brand
+|[[Datei:EN-US.png]] therapeutic brand
 | colspan="2" |<p>Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics> Examples: Zantac for Tagamet</p>
 |-
 |3-L
 |'''TG'''
-|[[Datei:EN-US.png]]therapeutic generic
+|[[Datei:EN-US.png]] therapeutic generic
 | colspan="2" |<p>Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands> Examples: Ranitidine for cimetidine</p>
 |-
 |1-L
 |'''F'''
-|[[Datei:EN-US.png]]formulary
+|[[Datei:EN-US.png]] formulary
 | colspan="2" |<p>Description: This substitution was performed or is permitted based on formulary guidelines.</p>
 |-
 |1-L
 |'''N'''
-|[[Datei:EN-US.png]]none
+|[[Datei:EN-US.png]] none
 | colspan="2" |<p>No substitution occurred or is permitted.</p>
 |}

@@ Zeile 9: / Zeile 9: @@
 | colspan=2 bgcolor="#F6F3EE"|''substanceAdminSubstitution''
 | bgcolor="#F6F3EE"|2.16.840.1.113883.5.1070
-| bgcolor="#F6F3EE"|2012-07-24T00:00:00
+| bgcolor="#F6F3EE"|2012-07-24
 | bgcolor="#F6F3EE"|definitiv
 |-
@@ Zeile 17: / Zeile 17: @@
 | bgcolor="#ECE9E4" colspan="2"|'''Beschreibung'''
 |-
 |}